ES8608890A1 - Preparado farmaceutico liquido a base de teofilina de efec- tos retardados y procedimiento para su obtencion - Google Patents
Preparado farmaceutico liquido a base de teofilina de efec- tos retardados y procedimiento para su obtencionInfo
- Publication number
- ES8608890A1 ES8608890A1 ES85547013A ES547013A ES8608890A1 ES 8608890 A1 ES8608890 A1 ES 8608890A1 ES 85547013 A ES85547013 A ES 85547013A ES 547013 A ES547013 A ES 547013A ES 8608890 A1 ES8608890 A1 ES 8608890A1
- Authority
- ES
- Spain
- Prior art keywords
- solution
- theophylline
- phytocolloid
- producing
- pharmaceutical preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
PROCEDIMIENTO PARA OBTENER UN PREPARADO FARMACEUTICO LIQUIDO DE TEOFILINA DE EFECTOS RETARDADOS. COMPRENDE: A) DILUIR UN FITOCOLOIDE EN AGUA A LA TEMPERATURA DE EBULLICION, PARA FORMAR UNA SOLUCION ACUOSA DEL MISMO; B) MEZCLAR PARTE DE LA SOLUCION ACUOSA DE FITOCOLOIDE CON UN JARABE, CON AGITACION Y ENTRE 40 Y 60JC; C) ESTABILIZAR LA PARTE RESTANTE DE LA SOLUCION ACUOSA DE FITOCOLOIDE A PH NEUTRO; D) DILUIR EL PRINCIPIO ACTIVO TEOFILINA EN LA SOLUCION ACUOSA DE FITOCOLOIDE DE C), ENTRE 40 Y 60JC; Y E) AÑADIR LENTAMENTE CON AGITACION CONTINUA Y A TEMPERATURA AMBIENTE LA SOLUCION DE D) SOBRE LA SOLUCION DE B) PARA LIGAR LA TEOFILINA ACTIVA AL FITOCOLOIDE, FORMAR UN COLOIDE DE FITOCOLOIDE EN LA FASE LIQUIDA DE GEL Y OBTENER UN PREPARADO FARMACEUTICO LIQUIDO. EL FITOCOLOIDE SE DERIVA DE ALGAS MARINAS Y ESTA CONSTITUIDO POR DOS FRACCIONES DE POLISACARIDOS AGAROSA Y AGAROPECTINA FORMADOS POR D-GALACTOSA Y 3,6-ANHIDRO-L-GALACTOSA CON DISTINTOS GRADOS DE POLIMERIZACION; EL JARABE ESTA FORMADO POR EDULCORANTES, AROMATIZANTES, COLORANTES, EXCIPIENTES Y VEHICULOS FARMACEUTICAMENTE ACEPTABLES Y EL PRINCIPIO ACTIVO DE TEOFILINA SE ENCUENTRA EN FORMA DE GEL.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES85547013A ES8608890A1 (es) | 1985-09-16 | 1985-09-16 | Preparado farmaceutico liquido a base de teofilina de efec- tos retardados y procedimiento para su obtencion |
CH1730/88A CH675683A5 (es) | 1985-09-16 | 1988-05-06 | |
EP88500049A EP0343306A1 (en) | 1985-09-16 | 1988-05-25 | Liquid pharmaceutical preparation based on theophylline with a retarding effect, and process for producing it |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES85547013A ES8608890A1 (es) | 1985-09-16 | 1985-09-16 | Preparado farmaceutico liquido a base de teofilina de efec- tos retardados y procedimiento para su obtencion |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8608890A1 true ES8608890A1 (es) | 1986-09-01 |
ES547013A0 ES547013A0 (es) | 1986-09-01 |
Family
ID=8489818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES85547013A Expired ES8608890A1 (es) | 1985-09-16 | 1985-09-16 | Preparado farmaceutico liquido a base de teofilina de efec- tos retardados y procedimiento para su obtencion |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0343306A1 (es) |
CH (1) | CH675683A5 (es) |
ES (1) | ES8608890A1 (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2068154A1 (es) * | 1993-07-13 | 1995-04-01 | Cantabria Ind Farmaceutica Sa | Nuevas formulaciones analgesicas con amplio intervalo de accion. |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602005007319D1 (de) * | 2005-02-17 | 2008-07-17 | Jordanian Pharmaceutical Mfg | Zubereitung zur kontinuierlichen Arzneimittelfreisetzung Chitosan enthaltend |
-
1985
- 1985-09-16 ES ES85547013A patent/ES8608890A1/es not_active Expired
-
1988
- 1988-05-06 CH CH1730/88A patent/CH675683A5/fr not_active IP Right Cessation
- 1988-05-25 EP EP88500049A patent/EP0343306A1/en not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2068154A1 (es) * | 1993-07-13 | 1995-04-01 | Cantabria Ind Farmaceutica Sa | Nuevas formulaciones analgesicas con amplio intervalo de accion. |
Also Published As
Publication number | Publication date |
---|---|
ES547013A0 (es) | 1986-09-01 |
CH675683A5 (es) | 1990-10-31 |
EP0343306A1 (en) | 1989-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003086295A3 (en) | Process for preparing tannate liquid and semi-solid dosage forms | |
JPS5356315A (en) | Emulsified solution of fat soluble drugs | |
FR2690846B1 (fr) | Forme galenique pour administration oculaire et procede de preparation. | |
IE873006L (en) | Salt of diclofenac with a cyclic organic base and¹pharmaceutical compositions which contain it | |
IT1212847B (it) | Protesi peniena semirigida per il trattamento dell'impotenza nella erezione maschile. | |
ES8608890A1 (es) | Preparado farmaceutico liquido a base de teofilina de efec- tos retardados y procedimiento para su obtencion | |
DE3477924D1 (en) | Benzenesulphonyl lactams, process for their preparation and their use as active ingredients in pharmaceutical compounds | |
Scotti de Carolis et al. | Electroencephalographic and behavioral investigations on" gabaergic" drugs: Muscimol, baclofen, and sodium! g-hydroxybutyrate: Implications on human epileptic studies. | |
GB1453234A (en) | Liquid vehicle for pharmaceutical compositions | |
AU8227587A (en) | Topical drug release system | |
CA2015632A1 (en) | Stable solutions of rebeccamycin analog and preparations thereof | |
FR2547814B1 (fr) | Derives de l'acide bicyclo (3.2.1.) octane carboxylique, leur procede de preparation et leur application therapeutique | |
IT1162680B (it) | N-(1-metil 2-pirrolidinilmetil) 2,3 dimetossi-5-metilsolfamoil benzammi de e suoi derivati utili per il trattamento dei disturbi dell'apparato urinario e procedimento di preparazione | |
JPS535270A (en) | Method of insolubilization of corrosible film of two components system consisted of polysaccharide and protein salt * to water | |
GR3005100T3 (es) | ||
SU1676628A1 (ru) | Противоалкогольное средство "Гликал | |
RU1216844C (ru) | Способ стимул ции охоты у крупного рогатого скота | |
SU391832A1 (ru) | Лекарственный препарат | |
BE781697A (fr) | Procede et dispositif pour l'administration au corps humain de produitsliquides, visqueux ou gras, sous une forme ionisee | |
Clensby | Direct Filtration of Surface Waters | |
IT1212524B (it) | Procedimento perfezionato per il trasferimento, dalla fase liquida alla fase gassosa, dell'ammoniaca in eccesso contenuta in soluzioni acquose di urea. | |
许国烈 | Taxi= Minibus= Van? | |
JPS5219647A (en) | Preparation of 3-aminomethyl-4- homoisotwistane and its acid addition salt | |
JPS53124686A (en) | Preparation of 5'-guanylic acid disodium/5'-inosinc acid disodium mixed crystal | |
ARICHI | The connection between the skin and the internal organs (Report 14) A study in the connection between the connective tissue and the stomach (2) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19970602 |